Catalyst Wire Dossier Catalyst Wire Dossier

Sovaldi

Sofosbuvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

57 regulatory and trial events tracked for Sovaldi, covering 2013-12-06 to 2026-01-09. Get the full timeline:

Most recent: EMA Authorised: Sovaldi (sofosbuvir) — Gilead Sciences Ireland UC

See pricing